Sean Godbout insider trades

Open-market stock purchases and sales by Sean Godbout, Chief Accounting Officer at Biogen Inc, from SEC Form 4 filings since Apr 1, 2025.

Recent trades

DateStockTradeValue
Apr 1, 2026BIIB Biogen IncSold (not open market)$9.9K
Apr 1, 2026BIIB Biogen IncBought (not open market)—
Feb 13, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncSold (not open market)$15.3K
Feb 6, 2026BIIB Biogen IncSold (not open market)$20.7K
Feb 6, 2026BIIB Biogen IncSold (not open market)$36.2K
Feb 6, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncBought (not open market)—
Oct 2, 2025BIIB Biogen IncSold (not open market)$1.2K
Oct 2, 2025BIIB Biogen IncBought (not open market)—

Companies traded

  • BIIB Biogen Inc: other filings, last Apr 1, 2026

Get free alerts when Sean Godbout files a new trade →